CurrentAetnaPolicy 0020

Injectable Medications

Customize your policy alerts

Sign up for Aetna Policy 0020 alerts

Get alerted when Policy 0020 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines Aetna's coverage stance for injectable medications, including medical necessity, exclusions, and special considerations (e.g., needle phobia) for members and providers.

Policy Summary

PayerAetna

PolicyInjectable Medications

Policy CodePolicy 0020

Change TypeRoutine review — no material changes

Effective DateOct 6, 1995

Last ReviewMar 6, 2023

Next Review DateJan 11, 2024

Key ActionObtain prior authorization per plan for injectable medications and related administration/drug codes.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

no oral alternativeprimary coverage condition

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentAetnaPolicy 0020

Injectable Medications

Customize your policy alerts

Sign up for Aetna Policy 0020 alerts

Get alerted when Policy 0020 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines Aetna's coverage stance for injectable medications, including medical necessity, exclusions, and special considerations (e.g., needle phobia) for members and providers.

Policy Summary

PayerAetna

PolicyInjectable Medications

Policy CodePolicy 0020

Change TypeRoutine review — no material changes

Effective DateOct 6, 1995

Last ReviewMar 6, 2023

Next Review DateJan 11, 2024

Key ActionObtain prior authorization per plan for injectable medications and related administration/drug codes.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

no oral alternativeprimary coverage condition

Coverage Criteria for Injectable Medications

Initial Coverage Criteria

Covered when ALL of the following are met

General coverage: The injectable medication is medically necessary and appropriate to the member's needs or condition and there is no appropriate oral alternative.

Needle phobia trial waiver: Requirement for a trial of injectable drug therapy may be waived if the member meets DSM-5 criteria for specific phobia (needle phobia) with documentation of preexisting excessive fear, documented attempts at management and psychological counseling, and any associated symptoms (e.g., vasovagal syncope, panic attack).

See appendix for DSM-5 criteria (persistence typically >= 6 months).

Coverage for certain injectable classes is limited or excluded depending on plan design, regulations, and the clinical indication. Contraceptive injectables are covered only under plans that include a contraceptives rider or a contraceptives benefit and in non-grandfathered plans subject to DHHS preventive service requirements. Immunizations for travel may be excluded. Anabolic steroids used for performance enhancement are not covered because that use is not considered treatment of disease. Infertility injectable medications are covered only when required by regulation or when a specific benefit design includes them; otherwise they may be excluded.

Injectable drugs that are experimental or investigational, or that have not been proven safe and effective for the specific disease or mode of treatment and are not approved by the FDA and/or NIH, are not covered. This exclusion does not apply to established off‑label uses of otherwise FDA‑approved prescribed medications.

Initial Therapy Rules

Initial Therapy

Initial therapy coverage rule

Initial: Injectable medication is covered when it is medically necessary and there is no appropriate oral alternative; trial requirements for injectable therapy may be waived for members with documented needle phobia per DSM-5 criteria and supporting documentation.

Documentation should include evidence of preexisting excessive fear, attempts at management, and psychological counseling.

Coding — Procedure and Diagnosis Codes

Covered CPT/HCPCS/J CodesmixedCovered

90281-90399	Immune globulins [intramuscular, intravenous, subcutaneous]
90471, 90472, 90474	Immunization administration for vaccines/toxoids [intradermal, intramuscular, percutaneous, subcutaneous]
90581-90658, 90666-90676, 90691-90710, 90713-90749	Vaccines, toxoids [intradermal, intramuscular, intravesicular, percutaneous, subcutaneous]
96365-96379	Therapeutic, prophylactic, and diagnostic injections and infusions
A4737, A9543, A9563, A9564, A9600-A9605, A9699	HCPCS codes related to injectable medications and supplies
C8957-C9235	HCPCS codes related to injectable medications
G0008-G0010, G0260, G0332, G3001	Administration and related codes
J0120-J0270, J0278-J2543, J2550-J3520, J3570-J3590, J7187-J7199, J7319, J9000-J9999	J-code drug billing range for injectable drugs
Q0081-Q0085, Q0515, Q2009-Q2017, Q3027, Q4079, Q4081-Q4086	Miscellaneous HCPCS Q-codes related to injectables
S0017-S0081, S0091-S0093, S0122-S0132, S0145-S0156, S0162-S0167, S0171, S5550-S5553	Supplier/service codes related to injectables

1–10 of 11

1/2

ICD-10 Codes ReferencedICD-10

F40.231	Fear of injections and transfusions
F40.298	Other specified phobia [needle phobia]

inv-06: Duration for phobia diagnosis — typically lasting for 6 months or more

Duration for diagnosisPersistent fear, anxiety, or avoidance typically lasting for 6 months or more

Clinical impactCauses clinically significant distress or impairment in social, occupational, or other important areas of functioning

Onset characteristicsPhobic object/situation almost always provokes immediate fear or anxiety and is actively avoided or endured with intense fear

Differential exclusionDisturbance not better explained by another mental disorder (e.g., agoraphobia, OCD, PTSD, separation anxiety, social anxiety disorder)

Pediatric presentationIn children, fear/anxiety may be expressed by crying, tantrums, freezing, or clinging

Provider Actions, Authorization & Documentation

Prior Authorization

Prior Authorization Required

Prior authorization is required per plan for injectable medications and related administration/drug HCPCS/CPT/J-series codes. Providers should obtain prior authorization before dispensing or billing for injectable therapies when the member's benefit plan requires it.

Applies to physician-administered and self-administered injectable drugs when plan benefit requires prior auth
Includes associated administration codes (e.g., relevant CPT/HCPCS/J-codes) where prior authorization is required

Step Therapy

Step Therapy Reference

Refer to the Pharmacy Clinical Policy Bulletins (PCPBs) for step therapy requirements for oral and self‑administered injectable medications. Providers should follow PCPB step-therapy pathways where applicable prior to requesting coverage for an injectable alternative.

See applicable PCPB for specific step therapy sequences and exceptions
Step therapy may apply to oral agents and certain self-administered injectables

Step Therapy and Related Pharmacy Rules

Step	Description / Reference
1	Medical necessity criteria for oral and certain self‑administered injectable medications are addressed in Pharmacy Clinical Policy Bulletins (PCPBs); step therapy requirements for these agents may be managed via the applicable PCPB.

Site of Care and Administration Settings

Note

Coverage applies to home (self‑administered) and clinical administration

Coverage includes medications intended to be self‑administered as well as those administered in clinical settings; coverage remains subject to plan‑specific rules and benefit design.

Verify member benefit design for site‑of‑care or plan exclusions (e.g., infertility injectables or contraceptive injectables).

Background

For this policy, injectable medications include agents administered via intramuscular, subcutaneous, intrathecal, or intravenous routes and encompass vaccines, immune globulins, therapeutic infusions, and other J‑code billed injectable drugs. Coverage applies to medications that are medically necessary and appropriate to the member’s condition, including those intended for self‑administration, subject to plan‑specific rules and benefit design.

Definitions

inv-13: Needle phobia (Specific phobia) — DSM-5 diagnostic criteria summary

Core criterionMarked fear or anxiety about a specific object or situation (e.g., receiving an injection or seeing blood)

Automatic reactionThe phobic object or situation almost always provokes immediate fear or anxiety

Avoidance or distressThe phobic object or situation is actively avoided or endured with intense fear or anxiety

Persistence thresholdThe fear, anxiety, or avoidance is persistent, typically lasting for 6 months or more

Functional impairmentFear, anxiety, or avoidance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning

Exclusion ruleNot better explained by symptoms of another mental disorder (e.g., panic-related situations, OCD, PTSD, separation anxiety, social anxiety)